Atlas FDA

RADIESSE, 1.3 CC AND 0.3 CC

FDA premarket approval P050052/S004 · decided 2008-04-21

Approval details

PMA number
P050052
Supplement
S004
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
RADIESSE, 1.3 CC AND 0.3 CC
Generic name
Implant, dermal, for aesthetic use
Applicant
Merz North America, Inc.
Date received
2007-05-18
Decision date
2008-04-21
Days to decision
339 days
Decision code
APPR
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Franksville, WI
Statement
APPROVAL FOR A MODIFIED PRODUCT THAT CONTAINS PHOSPHATE BUFFER SOLUTION, HAS A LOWER EXTRUSION FORCE THAN THE ORIGINAL RADIESSE PRODUCT, AND IS MANUFACTURED USING A ONE-STEP PROCESS.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
DESCRIBE PFD Patch (K172689)Merz North America, Inc.2017-11-29